Navigation Links
Dyadic Netherlands Enters Into R&D Collaboration With Sanofi Pasteur and EnGen Bio
Date:5/2/2011

onstrate the utility of our C1 technology for certain vaccine applications."

About Dyadic

Dyadic is a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the biopharmaceutical, biofuels and industrial enzyme industries. Dyadic utilizes an integrated technology platform based on its patented and proprietary C1 fungus, which enables the development and large scale manufacture of low cost proteins and enzymes for diverse market opportunities. The C1 Platform Technology can also be used to screen for the discovery of novel genes and proteins. Dyadic actively pursues licensing arrangements and other commercial opportunities to leverage the value of these technologies by providing its partners and collaborators with the benefits of manufacturing and/or utilizing the enzymes which these technologies help produce. Please visit Dyadic's website at www.dyadic.com.

Dyadic Netherlands is a wholly owned subsidiary of Dyadic based in Wageningen, The Netherlands that is dedicated to research and development activities for the benefit of Dyadic, its collaborators and customers. Please visit Dyadic Netherlands' website at www.dyadic.nl.

Cautionary Statement for Forward-Looking Statements

Certain statements contained in this press release are forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause Dyadic's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Except as required by law, Dyadic expressly disclaims any intent or obligation to update any forward-looking statements.


'/>"/>
SOURCE Dyadic International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. New U.S. Patent Issued to Dyadic International
2. Dyadic International to Present at Advanced Biofuels Leadership Conference
3. Dyadic International Introduces Advanced Biofuels Enzyme AlternaFuel® CMAX™ At World Biofuels Markets
4. Dyadic International Reports 2010 Fiscal Year Financial Results
5. Dyadic International Launches High Performance Enzyme for Pulp and Paper Industry Using New C1 Production Platform
6. Dyadic International Reports 2010 Third Quarter Financial Results
7. Dyadic International to Announce Third Quarter 2010 Financial Results and Hold Conference Call on November 15, 2010
8. Dyadic International Raises $3 Million in Private Placement of Convertible Notes
9. Dyadic International to Announce Second Quarter 2010 Financial Results and Hold Conference Call on August 13, 2010
10. Dyadic International Announces Final Resolution and Dismissal of Stockholder Class Action Lawsuit
11. Dyadic International Engages The Abraham Group as Strategic Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... RESEARCH TRIANGLE PARK, N.C. , April 21, ... ) announced today that it will release its first ... April 28, 2015. United Therapeutics will host ... 9:00 a.m. Eastern Time.  The teleconference is accessible by ... of the teleconference will be available for one week ...
(Date:4/21/2015)... A leading manufacturer of stainless steel ... discuss its custom fabrication services today at INTERPHEX 2015. ... launched just prior to the INTERPHEX event. The expo ... and 23) at the Javits Center in New York ... largest and most innovative pharmaceutical and biotech firms will ...
(Date:4/20/2015)... Stent retriever thrombectomy, an endovascular technique ... brain reduced disability after stroke, according to a ... of the Society of Vascular and Interventional Neurology ... step forward that will change the way we ... Jovin, who is associate professor of Neurology and ...
(Date:4/20/2015)... WORTH, Texas , April 20, 2015 ... orthopedic surgeons for healing bone injuries. The orthobiologics market ... growth opportunities for its stakeholders. The global orthobiologics market ... and forecast of revenue. The global orthobiologics market was ... to reach $7,900.2 million by 2019, at a CAGR ...
Breaking Biology Technology:HOLLOWAY AMERICA to Reveal Newly Designed Responsive Website at INTERPHEX 2015 Today 2HOLLOWAY AMERICA to Reveal Newly Designed Responsive Website at INTERPHEX 2015 Today 3SVIN President Tudor Jovin, MD, Co-Leads Groundbreaking Stroke Study In The New England Journal Of Medicine 2SVIN President Tudor Jovin, MD, Co-Leads Groundbreaking Stroke Study In The New England Journal Of Medicine 3Global Orthobiologics Market is Expected to Reach $7,900.2 Million by 2019, at a CAGR of 6.7% from 2014 to 2019 2Global Orthobiologics Market is Expected to Reach $7,900.2 Million by 2019, at a CAGR of 6.7% from 2014 to 2019 3
... Campbell Alliance, the leading,management consulting firm specializing ... leaders from its Sales Practice will conduct,two speaking ... Summit on Evolving the Pharma Sales Model, to ... Doubletree Hotel in Philadelphia, PA., An award-winning ...
... 4 Zimmer Holdings, Inc.,(NYSE: ZMH ; SWX: ... acquire the Abbott Spine business from Abbott for approximately,$360 ... the purchase price,from cash on hand and borrowings under ... close in the fourth quarter of 2008. The,boards of ...
... The Hamner Institutes and The University of North Carolina-Chapel ... Research Partnership in Drug Safety Sciences, RESEARCH TRIANGLE ... Sciences and the University of North Carolina at,Chapel Hill ... Safety,Sciences that will be led by Dr. Paul Watkins, ...
Cached Biology Technology:Campbell Alliance Sales Practice to Present at CBI's Leadership Summit on Evolving the Pharma Sales Model 2Campbell Alliance Sales Practice to Present at CBI's Leadership Summit on Evolving the Pharma Sales Model 3Campbell Alliance Sales Practice to Present at CBI's Leadership Summit on Evolving the Pharma Sales Model 4Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology 2Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology 3Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology 4New Hamner-UNC Center for Drug Safety Sciences 2New Hamner-UNC Center for Drug Safety Sciences 3
(Date:3/19/2015)... , March 19, 2015  NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces its ... a news clip that aired this week on ... . In a segment "The Next Great Thing", ... ,a new way to pay, and ,a really big breakthrough ...
(Date:3/17/2015)... 17, 2015 MedNet Solutions , ... clinical study management systems, is pleased to announce ... ARENA,s Outsourcing in Clinical Trials Southeast conference – ... an excellent forum for MedNet to showcase ... software-as-a-service (SaaS) eClinical technology platform. We ...
(Date:3/17/2015)... 17, 2015  MecklerMedia Corporation (OTCQX: MECK) announced ... service robots ever held in New ... May 11-13, 2015 at the Javits Convention Center. ... event include: Acorn Product Development; Axis NJ; c-Link ... Robotics; Littler; NewBotic Corporation; Neya Systems LLC; Reliabotics; ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
... ARBORMany medically minded researchers are in hot pursuit of ... and the interiors of cells, but University of Michigan ... to overcome: escaping the bloodstream. Drug delivery ... medicines could be more effective at lower doses and ...
... UK dog population is estimated to be around ten million, ... New research has shown that dogs act as a ... can potentially contaminate the public environment and infect humans. ... and colleagues from the University of Bristol,s School of Veterinary ...
...  Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of synthetic ... today that its Chief Executive Officer, Jeffrey Riley ... Investor Conference. The conference will be held February 11-12, 2013 ... . Mr. Riley is scheduled to present on Tuesday, ...
Cached Biology News:Achilles heel: Popular drug-carrying nanoparticles get trapped in bloodstream 2Achilles heel: Popular drug-carrying nanoparticles get trapped in bloodstream 3Caring for dogs to reduce spread of parasite eggs harmful to humans 2Synthetic Biologics to Present at the 2013 BIO CEO & Investor Conference 2
Mouse monoclonal [CIG 3A11/5] to Cig2 (rating: *****) ( Abpromise for all tested applications)....
Phospho-CD18 (Ser756/Thr758/759) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Goat polyclonal to SART1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: GSSKKHRGEKEAA, corresponding to N terminal amino acids 2-14 of Human SART1. Entrez Gene ID: 909...
Phospho-Cyclin D1 (Thr286) Antibody...
Biology Products: